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Infiltration of the tumor microenvironment (TME) by immune and inflammatory cells is involved in promoting tumorigenesis, tumor progression, local invasion and metastasis.
(1) Tumor-associated macrophages (TAMs), a prominent and abundant inflammatory component of solid and hematological malignancies, express a pro-and anti-tumor effect in all stages of carcinogenesis. The molecular and functional phenotype of TAMs plays a key role in the tumorigenesis and progression. (2) A malignant tumor contains not merely proliferating neoplastic cells, but many other cells which constitute a microenvironment, for example, endothelial cells, fi broblasts, and infi ltrating immune cells. TAMs, one of the important infiltrating immune cells, secrete an array of cytokines, chemokines, and enzymes that affect tumor progression, metastasis, and resistance to therapy. (3, 4) TAMs secrete an array of cytokines, chemokines, and enzymes that affect tumor progression, metastasis, and resistance to therapy. (5) (6) (7) Clinical success in targeting macrophage (MΦ) in tumor patients suggests that TAMs might by attractive targets in combination therapy for tumor treatment. (8, 9) Chinese medicine (CM) is an important complementary medicine parallel to the conventional medicine system for tumor patients in China and other Asian countries. Chinese materia medica (CMM) is the natural therapeutic agent used under the guidance of CM theories. (10) multi-component, multi-targeted and dual-regulatory function. (11) One of the mechanisms of CMM tumor therapy is related to regulating the internal environment and remodeling the TME, which coincides with conventional tumor therapy targeting the TME. CMM prescriptions, consisting of a single herb or combination of several herbs based on the theory of CM, have been used for treating and preventing various cancers during long-term popular practice or in combination therapy with chemotherapeutics. (7, 12, 13) The potential mechanism of anti-tumor effects of CMM includes increasing the effi cacy of the therapeutic effect of chemotherapeutics including decreasing the development of chemoresistance or regulating the immune system. (14) (15) (16) It has been shown that CMMs have the effects of enhancing the immunological surveillance, regulating the body's internal milieu and remodeling the TME. (13) In this article, we briefly introduce the origin, subpopulations, phenotypic characteristics and polarization of TAM and the TAM's effect on the TME in promoting tumorigenesis, metastasis, and immune suppression. Specifi cally we analyzed the effects and mechanisms of CMM prescriptions, extracts or active compounds on targeting TAMs in anti-tumor therapies. We also discuss the CMM's dual-regulatory and multitargeting functions on regulating TAM, and hopefully, provide the theoretical basis for CMM use in clinical practice for cancer therapy.
Origin, Subpopulation and Polarization of TAM
MΦs involved in the immune responses appear to generate from circulating bone marrow monocytes, and are recruited to the TME by cytokines secreted by the tumor cells and other cells, then differentiated into various phenotypes and functions including anti-or pro-tumor activities. (5, 17, 18) Subpopulations of MΦ In in vitro models, MΦs have been classifi ed as proinflammatory, classically activated MΦs (M1) and antiinfl ammatory; alternatively activated MΦs (M2) based on their cell surface phenotypes and secreted cytokines.
M1-type MΦs, induced by Th1 mediators such as interferory (IFN)-γ, tumor necrosis foctor α (TNF-α) or lipopolysaccharides (LPS), release pro-infl ammatory cytokines such as interleukin (IL)-12, IL-23. They express major histocompatibility complex (MHC) Ⅱ molecules, and have a high IL-12/IL-10 secretion ratio. M1 MΦs participate in the Th1 infl ammatory responses primarily through production of pro-inflammatory mediators and up-regulation of cell surface molecules necessary for antigen presentation to activate Th1 cells and enhance the ability to phagocytose pathogenic material. (19, 20) M2-type MΦs, typically induced by Th2 cytokines, mediate resistance to parasites, mediate immune regulation and tissue repair. (4, 21) M2 MΦs release high levels of IL-10 and low levels of IL-12 and IL-23. In the context of cancer, however, M2 MΦs help driving tumor growth through the promotion of angiogenic programs, tissue remodeling, and directly or indirectly suppress cytotoxic T cell activity. (22) The classifi cation of MΦs in type M1 versus type M2 is an oversimplifi cation of the in vivo situation. Most recently, Mosser and colleagues (23) suggested a new grouping of MΦ populations based on fundamental MΦ functions. This form of classification, though it may better reflect the heterogeneity and plasticity of MΦs in the TME, is clearly more diffi cult to consider and apply to research. The classical classifi cation in M1/M2 MΦs is still commonly used as a valid and accepted concept for the sake of clarity.
Polarization of MΦ MΦs can be phenotypically polarized into diverse functional phenotypes by different microenvironment, and could have different effects during early or late tumor progression. (24) Tumor escape has been linked to a polarization switch from M1 to M2 MΦ phenotypes. In the early steps of tumor initiation, TAMs were mostly polarized towards a M1-like phenotype while during later steps of tumor progression they polarized mostly toward a M2-like phenotype. (24, 25) In contrast, Wang, et al (26) reported a pro-metastatic role of M1-like TAM (CD68 + HLA-DR + ) in hepatocellular carcinoma. This difference may be due to the different and complex environments of various cancers observed in vivo, which cannot yet be easily simulated in vitro. Many chemokines, such as C-X-C motif chemokine 12 (CXCL12), (27) and chemokine ligand 2 (CCL2), (28) signaling pathways, such as nuclear factor κB (NF-κB), (29) Notch receptors, (30) or hypoxia present in the TME (28) contribute to the polarization of TAM. The details of TAM function and CMM targeting MΦs will be presented below.
Effects of TAMs during Carcinogenesis and Antitumor Mechanisms of CMM Targeting TAMs
Many observations indicate that TAMs possess M2-associated pro-tumor functions, including the induction of tumor angiogenesis and the stimulation of tumor cell proliferation, survival and invasion by producing inflammatory mediator, such as cytokines, and matrix metalloprotease (MMPs), or suppressing the cytotoxic effect of T cells. (2, 31) TAMs play an important role in growth, metastasis and immunosuppression. Recently, studies showed that "TAM-specifi c therapies" may be a suitable option for further therapeutic approaches in cancer. Thus, CMM targeting TAMs may be considered as an additional anti-tumor therapy applicable to multiple stages of carcinogenesis. (19, 32) Tumor Initiation
It is now widely accepted that the nonmalignant cells of the TME evolve along with the growing tumor and provide essential cues supporting the modulation of TAM phenotype. (5) Chronic infl ammation was shown to be associated with the development of malignant tumors by creating a tumor-promoting microenvironment. (33) MΦs are recruited to different areas of the TME and educated toward different phenotypes. (17, 18) It has been shown that pancreatic cancer cells could activate MΦs in vitro to polarize toward an M2-phenotype, through the cytokines IL-4, IL-10 and CCL2. (34, 35) This effect was confi rmed by in vivo results revealing about 90% of all TAMs to be M2 MΦs. Accordingly, depletion of MΦs in vivo resulted in a signifi cantly reduction in tumor growth. (36) Some Chinese herbal ingredients or prescriptions have been confi rmed to effectively inhibit the recruitment and activation of MΦs to tumor sites and to re-educate TAM (see below).
Recruitment and Activation of TAMs
Diverse cytokines and polypeptides produced by tumor cells as well as microenvironment, such as hypoxia, are involved in guiding the recruitment, positioning and function of TAMs in the TME. (3) For example, CCL2, plays a pivotal role in many cancers, including pancreas, ovary, and breast in the recruitment and infi ltration on MΦ into the TME. (34, 35, 37) In a pancreatic cancer mouse model, the inhibition of CCL2 was shown to reduce the recruitment of TAMs into the tumor, to improve the response to gemcitabine and increase the antitumor T-cell response and further inhibit tumor metastasis. (37, 38) CMM may regulate the recruitment and activation of MΦs in the TME by various pathways. Berberine, an isoquinoline alkaloid isolated from many medicinal herbs, such as Coptis chinensis Franch, inhibited the growth of CT26 tumor cells implanted subcutaneously in BABL/c mice and signifi cantly reduced the density of CD68 + /CD206 + TAMs. This is consistent with the notion that the anti-tumor effect of berberine involves inhibition of TAMs recruitment. (39, 40) Epigallocatechin gallate (EGCG), a polyphenol present in green tea, inhibited tumor growth in a murine breast cancer model by inhibiting TAM infiltration and M2 MΦ polarization. (41, 42) Praeruptorin D and E, the main constituents of Peucedanum praeruptorum Dunn, could protected BALB/c mice from lipopolysaccharide (LPS)-induced acute lung injury by inhibiting MΦs infi ltration to the lung, cytokine release and vascular permeability. 
A s t r a g a l u s p o l y s a c c h a r i d e s ( A P S ) , t h e polysaccharide fraction of the roots of Astragalus membranaceous, were reported to activate MΦs in a toll-like receptor 4 (TLR4)-dependent manner while activating B cells via membrane Ig in a TLR4-independent manner. (45) Abrus agglutinin is a lowtoxicity protein from the plant Abrus precatorius L. In its native (NA) and heat-denatured (HDA) forms, it activated TAMs in Dalton's lymphoma-bearing mice, and significantly increased in vitro cytotoxicity against tumor cells and stimulated production of nitric oxide but not of TNF-α. Thus, NA and HDA could be used as regulators of TAMs, for the treatment of cancer. (47) KSG-002, a 30% ethanolic extract of Astragalus membranaceous and Angelica Sinensis gigas at 3:1 w/w ratio, suppressed xenograft tumor growth and pulmonary metastasis via inhibiting TAM recruitment by blocking NF-κB-dependent TNF-α production. (48) 
Re-programing of TAM Phenotype
Mantovani proposed that TAM exert pleiotropic functions that can influence tumor growth and progression in opposite directions. (35) Recently, researches confirmed that circulating monocytes were recruited to the TME by chemotactic factors produced by tumor cells and differentiated toward the M2 phenotype. (52) (53) (54) M2 MΦs release various growth factors and cytokines to promote tumor cell invasion, induce angiogenesis, suppress antitumor immunity, and accelerate tumor cell metastasis. (55, 56) The polarization of TAM was a regulated and reversible process and dependent on the TME. It was shown that a predominance activation of NF-κB and signal transducers and activators of transcription (STAT) 1 promoted M1 MΦ polarization resulting in cytotoxic and infl ammatory activities, while STAT3 and STAT6 activation resulted in M2 MΦ polarization leading to immune suppression and tumor progression. (57, 58) CMM targeting TAMs could act as an anti-tumor prescription by aiming at preventing polarization of TAMs toward a more anti-tumor phenotype. Emodin, a natural anthraquinone derivative isolated from Rheum palmatum L., inhibited MΦ recruitment and M2 polarization by suppressing STAT6 phosphorylation and C/EBPB expression in the 4T1 and EO771 orthotopic breast cancer mouse models. (59, 60) Isoliquiritigenin (ISL), a flavonoid from Glycyrrhiza uralensis Fisch, inhibited M2 MΦ polarization by down-regulating PGE 2 and IL-6-mediated signaling in a mouse model of AOM/DSS-induced colitisassociated tumorigenesis. In parallel, ISL also blunted the M2 polarization of RAW264.7 cells and mouse peritoneal MΦs by inactivating PGE 2 /peroxisome proliferator-activated receptor δ and IL-6/STAT3 signaling in vitro. (61) Sinomenine, an alkaloid extracted from Sinomenium Acutum, has been used to treat rheumatism in China. Zhang, et al (62) found that treating breast cancer-bearing mice with 100 mg/kg sinomenine hydrochloride (SH) can provide a self-reinforcing stimulus for further polarizing TAMs away from an M2-like phenotype toward an M1-like phenotype thereby contributing to its anti-tumor and anti-metastasis effect. The aqueous extract of Crinum latifolium L. leaf induced expression of TNF-α, IL-1β and IL-6 and promoted MΦs differentiation into the pro-infl ammatory M1 phenotype. 
In some excessive inflammatory reactions, active CMM components could promote phenotype transition from M1 to M2, thus acting as anti-inflammation drug. Berberine down-regulated the content of TNF-α and the mRNA expression levels of inducible nitric noxide synthase (iNOS) and suppressor of cytokin signaling (SOCS) 3 in MΦs induced by LPS, inhibited the content of IL-10 and the mRNA expression level of Arg-1 in MΦs induced by IL-4, but did not modify SOCS2. The results indicate that berberine has an effect on inhibiting the M1 and M2 polarization of MΦs in vitro and may play a regulatory role in the dynamic balance of M1/M2 phenotype. (66) The similar results were found in many compounds or CM prescription, such as curcumin, (67) arctigenin, (68) and Xuebijing Injection (血必净注射液). (52) Importantly, CMM can act in a dual-regulatory function in the infl ammatory reaction depending on the specific physiological or pathological processes and the tissues involved. CMM can suppress excessive infl ammation, while promoting the polarization of antiinflammatory M2 MΦs into M1 phenotype thereby altering the state of immuno-suppression in the TME of advanced cancers.
Tumor Metastasis
The process of metastasis represents a critical phase in the neoplastic cascade, and growing evidence indicate a tight link between metastasis and TAMs, whereby TAMs produce inflammatory cytokines, stimulate the growth of tumor cells and promote tumor cell migration and metastasis. TAMs contribute to tumor progression also by producing several factors enhancing angiogenesis and lymphogenesis. (34, 69) T A M s h a v e b e e n r e p o r t e d t o p r o m o t e angiogenesis via the production of diverse proangiogenic factors such as transforming growth factor-β (TGF-β), VEGF, Platelet derived growth factor (PDGF), fibroblast growth factor (FGF) and angiogenic chemokines, such as CXCL12. (70, 71) They also regulate matrix degradation through the production of matrix-degrading enzymes such as MMPs, plasmin, and urokinase-type plasminogen activator (uPA). (69, 72) Clinical research has confirmed that M2-polarized TAMs are associated with poor prognoses in several cancers, including classical Hodgkin's lymphoma (CHL), (73) lung adenocarcinoma, (74) and pancreatic cancer. (75) Ding, et al (76) found a significant correlation between the expression of CD68 or CD163 protein with a tumor size, lymph node metastasis, and vascular invasion in patients with pancreatic cancer consistent with the role of TAM infi ltration in pancreas and the promotion of pancreatic cancer development.
Angiogenesis and Lymphangiogenesis
Angiogenesis and lymphangiogenesis are critical processes for tumor growth, invasion, and metastasis. TAMs promote angiogenesis in a wide type of tumors, such as gliomas, carcinomas of the esophagus, breast, bladder, and prostate by releasing vascular growth factors (mainly VEGF and PDGF), cytokines (e.g. TGF-β), proteases, and chemokines. (77) TAMs support tumor lymphangiogenesis not only by secreting prolymphangiogenic factors, such as VEGF-A and MMP-9, but also by trans-differentiation into lymphatic endothelial cells. (78) Wogonin, a flavonoid isolated from the root of Scutellaria baicalensis, inhibited tumor growth, metastasis, angiogenesis and lymphangiogenesis, and reduced the number of TAM in the tumors of LM8-bearing mice. Wogonin inhibited VEGF-C-induced lymphangiogenesis through the reduction of VEGF-Cinduced VEGF receptor-3 phosphorylation. (79) Recently a phenolic alkaloids of Menispermum dauricum (PAMD) inhibited BXPC-3 tumor growth and angiogenesis by reducing the production of VEGF, and basic fi broblast growth factor (bFGF). (80) Many results show that genistein, a soy isoflavonoid, inhibited angiogenesis through the regulation of VEGF, MMPs, and epidermal growth factor receptor expressions, thereby resulting in a strong anti-tumor effect. (红景天注射液), a CMM standardized Tibetan herbal product extracted from Rhodiola crenulata L., used to treat patients with acute ischemic stroke or coronary heart disease, inhibited the metastasis of human non-small cell lung cancer by reducing the production of VEGF. (86) Matrix Remodeling
In the tumor stroma, MΦs can produce enzymes promoting matrix degradation, such as MMPs, uPA and uPA receptor, and plasmin, thereby facilitating invasion and metastasis of tumor cell. (34) Emodin exerts anti-proliferative and anti-metastatic activity in pancreatic cancer both in vitro and in vivo, which may be related to the down-regulation of NF-κB and its regulated molecules survivin and MMP-9. (87) Gallic acid and gallic acid dimmer, polyphenols extracted from pericarp of water caltrop, significantly decreased MMP-9 activity and inhibited migration of gastric cancer cells; TNF-α and IL-6 associated with migration and angiogenesis were also significantly reduced. (88) Aloe emodin, an anthraquinone from Rheum palmatum L., has anti-migratory and anti-angiogenic activities in colon cancer cells by down-regulating expression of MMP-2/9, RhoB and VEGF. (89) Honokiol, a major phenolic compound isolated from the root and stem bark of magnolia, inhibited the expression of MMP-9 in PANC-1 cells in vitro and VEGF in tumor tissue in vivo in an athymic mouse tumor model. (90) Immune Suppression
TAMs also produce various immune suppressive factors, including PGE 2 , indoleamine 2,3-dioxygenase, Arg-1, and IL-10 to suppress tumor-associated antigen-specific T cell immunity and thus contribute to immunosuppression. (31, 34) The major immune stimulatory cytokine IL-12 may be due to the activity of IL-10, produced either by TAM or by the tumor cells. Part of the immune suppressive activity of TAM is exerted indirectly by their release of chemokines, such as CCL18 and CCL22 that preferentially attract T cell subsets devoided of cytotoxic functions. (91) These immune stimulatory cytokines and chemokines could be the potential targets of anti-tumor CMM. Different reports indicate that polysaccharides from CMM herbs could improve the amount of MΦs in the TME, enhance phagocytosis, as well as stimulate the secretion of NO, TNF-α, IL-1, etc., possibly related with M1 MΦs activation and polarization. (92) Direct Effect on MΦs PAC-I, a mannose-rich polysaccharide fraction from Aloe vera L. var. chinensis (Haw) Berg., increased the expression of MHC-Ⅱ and FcγR, and enhanced endocytosis, phagocytosis, NO production, TNF-α secretion and tumor cell cytotoxicity in vitro, stimulated systemic TNF-α production in vivo and prolonged the survival of tumor-bearing mice. The results may have therapeutic implications of PAC-I in tumor immunotherapy. (93) Regulation of Immune System Salidroside, an active component of Rhodiola rosea L., promoted proliferation and phagocytosis of peritoneal MΦs stimulated by LPS and IFNγ, and reduced the production of reactive oxygen species, but promoted the production of NO, and in activated peritoneal MΦs. (94) Li, et al (95) Polysaccharide, (100, 101) Polyporus polysaccharide, (102, 103) Plantago asiatica L. Polysaccharide, (104) Ganoderma lucidum Polysaccharide. (105) These effects induced anticancer effect indirectly though the activation of immune cells rather than via direct cytotoxic effects. (106, 107) Watersoluble polysaccharide extracted from Sanguisorba offi cinalis L., signifi cantly inhibited the growth of mouse transplanted tumor, remarkably increased the spleen index and promoted splenocytes proliferation, MΦ phagocytosis and secretion of serum cytokines IL-2, TNF-α and IFN-γ in sarcoma 180-bearing mice in the absence of direct cytotoxic activity on tumor cells. These results indicated that the anti-tumor activity of SOP may be achieved through immune potentiation. (108) These results were confirmed by other researchers using different CMM, such as polysaccharide from Limonium sinense Kuntez, (109) Lilium sp., (110) G. lucidum (111) and Weikangfu Granule (胃康复胶囊), a drug preparation used to treate gastric cancer and consisting of Curcuma wenyujin, Astralagus membranaceous, Glycyrrhiza infl ate, Poria coco, (112) 
Conclusion
CM, respectively CMM, belongs to a natural medicine system, which is still in active practice as an alternative therapeutic possibility beyond the origin cultural region. Based on this medicine system, many new medications have been developed, such as compounds isolated from Artemisia annua, and minnelide (a potential anti-pancreatic cancer medication, modifi ed from triptolide). (117) (118) (119) In the last two decades, experimental and clinical evidence showed that most chronic diseases, including cancer, are caused by a dysregulated inflammatoryimmune response，and TAMs are a key link between inflammation and cancer in regulating tumor growth, progression and response to anticancer drugs. (120) CMM demonstrated obvious anti-tumor effects based on its characteristics of multi-components and multitargets. The anti-cancer properties of CMM targeting TAMs were shown to involve the following mechanisms: (1) inhibition of the production of cytokines or chemokines associated with TAM recruitment and activation; (2) promotion of MΦs phenotype conversion from M2 to M1; (3) reduction of the production of protumoral cytokines secreted by TAM including angiogenic and lymphangiogenic factors; (78) (4) reshaping of the TME to inhibit the immunosuppressive responses.
Most fi ndings of anti-tumor CMM targeting MΦs or immune regulation are related to the expression level of cytokines or chemokines in the TME. More investigations are required, however, to unravel the mechanism involved and identify active components of CMM prescriptions. CMM prescriptions are highly complex systems, and interactions between different components commonly exist. (121) For example in the case of extracts of radices Astragalus membranaceous and Angelica sinensis in different proportions (e.g. w/w ratio) opposite effects related to cancer pulmonary metastasis were observed and should be investigated. (48) In this article, we have analyzed the literature for studies focused on cancer therapy related to CM and CMM. It is not just limited to active single substances, classical prescriptions, but it also includes combinations with conventional therapies, and the putative targeting phase in cancer development as listed in Figure 1 . Further investigations are required to better characterize the anti-tumor effects of CM and CMM. In order to develop novel anti-tumor therapies based on CMM it will be essential to confi rm results obtained in in vitro studies addressing molecular mechanisms of action on TAMs by performing in vivo studies on tumor progress. (122) 
Figure 1. Anti-tumor CMMs Targeting TAMs Effects on Tumor Progression
N o t e s : P r e -m a l i g n a n t o r m a l i g n a n t c e l l s a n d microenvironments, such as infl ammation or hypoxia, generated various cytokines, chemokines, and enzymes to recruit and activate macrophages. The TAMs, interacted with TME and other cells, re-programmed into diverse functional phenotypes to affect tumor initiation, metastasis, and immune suppression. Anti-tumor CMM compounds or prescriptions targeting TAMs could effect on different phases of tumor growth through different mechanism. 
